{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "A combination of its drugs slightly improved lung function of patients with the genetic disease in trials closely watched by Wall Street.", "headline": {"main": "Vertex&#8217;s 2-Drug Cystic Fibrosis Pill Shows Promise", "print_headline": "Vertex\u2019s 2-Drug Cystic Fibrosis Pill Shows Promise"}, "abstract": "Vertex Pharmaceuticals says combination of two of its drugs have successfully treated cystic fibrosis in closely watched clinical trials; results potentially clear way for approval of new option for nearly half of patients with genetic disease.", "print_page": "8", "word_count": "1058", "_id": "53a95a6179881006ebaebc9a", "snippet": "A combination of its drugs slightly improved lung function of patients with the genetic disease in trials closely watched by Wall Street.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/06/25/business/international/vertexs-two-drug-cystic-fibrosis-treatment-shows-promise-in-clinical-trials.html", "multimedia": [{"subtype": "wide", "url": "images/2014/06/25/business/25cystic-pic1/25cystic-pic1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/06/25/business/25cystic-pic1/25cystic-pic1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/06/25/business/Cystic1/Cystic1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/06/25/business/Cystic1/Cystic1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/06/25/business/Cystic1/Cystic1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/06/25/business/Cystic1/Cystic1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "International Business", "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Vertex Pharmaceuticals Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Cystic Fibrosis", "is_major": "Y", "rank": "2", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-06-25T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 1, "offset": 0, "time": 37}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}